HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hirofumi Mukai Selected Research

Gemcitabine

1/2020Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer.
12/2013Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hirofumi Mukai Research Topics

Disease

101Breast Neoplasms (Breast Cancer)
12/2023 - 03/2002
48Neoplasms (Cancer)
03/2024 - 03/2002
19Neutropenia
09/2021 - 03/2007
7Neoplasm Metastasis (Metastasis)
10/2022 - 10/2012
6Stomatitis
04/2021 - 11/2014
5Fatigue
10/2022 - 04/2010
5Diarrhea
09/2021 - 07/2008
5Disease Progression
09/2016 - 02/2009
4Leukopenia
09/2021 - 06/2007
4Febrile Neutropenia
04/2021 - 02/2011
4Prostatic Neoplasms (Prostate Cancer)
12/2017 - 04/2014
4Exanthema (Rash)
10/2016 - 07/2008
4Carcinoma (Carcinomatosis)
07/2013 - 02/2003
3Peripheral Nervous System Diseases (PNS Diseases)
12/2022 - 10/2020
2Pathologic Complete Response
11/2023 - 08/2014
2Mucositis
04/2021 - 01/2020
2Lymphatic Metastasis
01/2021 - 08/2010
2Alopecia (Baldness)
11/2020 - 10/2016
2Thrombocytopenia (Thrombopenia)
01/2019 - 10/2015
2Vomiting
03/2017 - 08/2010
2Nausea
03/2017 - 08/2010
2Dyspnea (Shortness of Breath)
11/2014 - 10/2012
1Cerebral Infarction
03/2024
1Hemorrhage
03/2024
1Venous Thromboembolism
03/2024
1Transient Ischemic Attack
03/2024
1Triple Negative Breast Neoplasms
11/2023
1Carcinoma in Situ
11/2023
1Second Primary Neoplasms (Neoplasms, Second)
01/2023
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2022
1Cognitive Dysfunction
08/2021
1Vascular Remodeling
07/2021

Drug/Important Bio-Agent (IBA)

23Trastuzumab (Herceptin)FDA Link
12/2022 - 03/2002
20Hormones (Hormone)IBA
01/2023 - 06/2010
18ErbB Receptors (EGF Receptor)IBA
10/2022 - 12/2012
15Estrogen ReceptorsIBA
12/2023 - 08/2010
15taxaneIBA
12/2022 - 08/2010
9palbociclibIBA
08/2022 - 06/2016
9human ERBB2 proteinIBA
03/2022 - 10/2009
7eribulinFDA Link
07/2021 - 10/2012
7exemestane (Aromasin)FDA Link
04/2021 - 05/2013
7EverolimusFDA Link
04/2021 - 05/2013
7Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 08/2010
7Docetaxel (Taxotere)FDA Link
03/2017 - 02/2003
6Aromatase InhibitorsIBA
01/2023 - 06/2010
6Letrozole (Femara)FDA LinkGeneric
08/2022 - 11/2014
5Lapatinib (GW572016)FDA Link
09/2023 - 01/2007
5Anastrozole (Arimidex)FDA LinkGeneric
01/2023 - 06/2010
5AnthracyclinesIBA
10/2021 - 01/2013
5Biomarkers (Surrogate Marker)IBA
10/2021 - 04/2010
5Taxoids (Taxanes)IBA
01/2016 - 08/2010
4130-nm albumin-bound paclitaxelIBA
12/2022 - 02/2021
4Epidermal Growth Factor (EGF)IBA
10/2021 - 01/2013
3Cyclin-Dependent Kinase 4IBA
08/2022 - 06/2016
3Fulvestrant (Faslodex)FDA Link
08/2022 - 03/2019
3Progesterone Receptors (Progesterone Receptor)IBA
10/2021 - 01/2016
3Dexamethasone (Maxidex)FDA LinkGeneric
04/2021 - 02/2003
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2020 - 06/2007
3Doxorubicin (Adriamycin)FDA LinkGeneric
07/2020 - 03/2007
3TamoxifenFDA LinkGeneric
11/2014 - 06/2010
3Cisplatin (Platino)FDA LinkGeneric
12/2013 - 02/2003
3Phosphotransferases (Kinase)IBA
02/2009 - 01/2007
2LigandsIBA
11/2023 - 05/2011
2abemaciclibIBA
08/2022 - 09/2021
2Anti-Bacterial Agents (Antibiotics)IBA
04/2021 - 07/2016
2GemcitabineFDA Link
01/2020 - 12/2013
2Antineoplastic Agents (Antineoplastics)IBA
01/2020 - 08/2010
2Carboplatin (JM8)FDA LinkGeneric
01/2020 - 01/2019
2NK105IBA
01/2019 - 12/2016
2Androgen Receptor AntagonistsIBA
12/2017 - 12/2017
2darolutamideIBA
12/2017 - 12/2017
2Fluorouracil (Carac)FDA LinkGeneric
01/2016 - 08/2010
2cabazitaxelFDA Link
10/2015 - 04/2014
2EnzymesIBA
11/2014 - 07/2008
2titanium silicide (TS-1)IBA
07/2014 - 08/2010
2Tyrosine (L-Tyrosine)FDA Link
02/2009 - 01/2007
1fibrin fragment D (D-dimer)IBA
03/2024
1pembrolizumabIBA
11/2023
1Estradiol (Delestrogen)FDA LinkGeneric
09/2023
1Fatty Acids (Saturated Fatty Acids)IBA
09/2023
1Glucose (Dextrose)FDA LinkGeneric
09/2023
1ElementsIBA
08/2022
1vinyltriethoxysilane (VTES)IBA
01/2022
1pyrimidineIBA
10/2021
1ParaffinIBA
10/2021
1TubulinIBA
10/2021
1Formaldehyde (Formol)FDA Link
10/2021
1pegfilgrastim (Neulasta)FDA Link
04/2021

Therapy/Procedure

46Therapeutics
12/2023 - 03/2002
40Drug Therapy (Chemotherapy)
11/2023 - 06/2003
9Neoadjuvant Therapy
11/2023 - 03/2007
6Drug Tapering
10/2022 - 10/2015
6Radiotherapy
04/2021 - 01/2013
4Adjuvant Chemotherapy
03/2022 - 12/2013
4Castration
12/2017 - 04/2014
3Combination Drug Therapy (Combination Chemotherapy)
01/2020 - 02/2003
3Complementary Therapies (Alternative Medicine)
01/2018 - 12/2006
2Duration of Therapy
01/2019 - 06/2018
1Ambulatory Care (Outpatient Care)
11/2022
1Time-to-Treatment
10/2022